Draft:BiondVax

Mar 13, 2018

BiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine Candidate

Feb 08, 2018

BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference

Jan 02, 2018

BiondVax Universal Flu Vaccine Patent Granted in India

Nov 20, 2017

BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine

Aug 31, 2017

Dual-Listed BiondVax to Voluntarily Delist from Tel Aviv Stock Exchange

Aug 14, 2017

BiondVax Receives Additional Grant Funding

Jun 28, 2017

BiondVax's CEO Provides First Half 2017 General Corporate Update